A Republican bill with 10 Democratic cosponsors · See all 13 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill is called the Safety Net Provider Drug Pricing Protection Act. It changes the Public Health Service Act to protect certain safety net healthcare providers. These providers will not have to pay more than the 340B ceiling price for covered outpatient drugs when they actually buy them. The bill stops the practice of paying more upfront and getting money back later through rebates or reimbursements. These new rules take effect right on the date the bill is enacted. They also apply to existing agreements that drug manufacturers have in place.
Yes
- Scored +6
Does this lower the price of prescription medicines?
The bill ensures safety net providers do not pay more than the 340B ceiling price for outpatient drugs at the time of purchase.
- Scored +5
Does this give people more protection from unfair business practices?
The bill protects certain safety net healthcare providers from paying inflated upfront drug prices and waiting for rebates.
- Scored +4
Would households on low incomes be better off under this?
By lowering immediate drug purchasing costs for safety net providers, it helps sustain healthcare access for low-income communities.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Section 2(a) makes sure that certain safety net providers do not have to pay more than the 340B ceiling price for covered outpatient drugs at the exact time of purchase. This is positive because it stops these providers from having to shell out extra money upfront.
-
Section 2(b) blocks any setup where a safety net provider pays more than the ceiling price at the time of purchase and has to wait for a later reconciliation by rebate, reimbursement, or other payment. This helps protect these providers from cash flow burdens by keeping their drug purchase costs down right away.
Potential Negative Impacts for People
- Based on the provided text, there are no negative impacts or burdens for individuals or groups of people explicitly mentioned in the bill.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this lower the price of prescription medicines? — The bill ensures safety net providers do not pay more than the 340B ceiling price for outpatient drugs at the time of purchase.
- Economy And Finance
- Does this give people more protection from unfair business practices? — The bill protects certain safety net healthcare providers from paying inflated upfront drug prices and waiting for rebates.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — By lowering immediate drug purchasing costs for safety net providers, it helps sustain healthcare access for low-income communities.
- 10/29/2026
- Referred to the House Committee on Energy and Commerce.
- 13 Cosponsors added.
- Introduced in House
Becca BalintDemocrat · Vermont
Emanuel CleaverDemocrat · Missouri
Sharice DavidsDemocrat · Kansas
Jared GoldenDemocrat · Maine
Pablo HernándezDemocrat · Puerto Rico
Tracey MannRepublican · Kansas
Seth MoultonDemocrat · Massachusetts
Eleanor NortonDemocrat · District of Columbia
Dan NewhouseRepublican · Washington
Raul RuizDemocrat · California
Austin ScottRepublican · Georgia
Melanie StansburyDemocrat · New Mexico
Dina TitusDemocrat · Nevada